Prévisions du marché des kits de tests rapides en Europe jusqu’en 2030 – Analyse régionale – par type (tests rapides d’antigènes, tests rapides d’anticorps et autres), produit (kit de tests rapides en vente libre et kit de tests rapides professionnels), technologie (dosage à flux latéral, Phase solide, agglutination, test Immunospot et basé sur les composants cellulaires), application (test de glycémie, test de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques et autres) et utilisateur final (hôpital et cliniques, soins à domicile, centres de diagnostic, et d\'autres)
Les initiatives stratégiques des fabricants stimulent le marché européen des kits de test rapide
Les fabricants du marché des kits de test rapide mettent l\'accent sur l\'adoption de stratégies tels que les innovations, les lancements et les approbations de produits pour maintenir un avantage concurrentiel sur le marché. De telles initiatives stratégiques des entreprises du marché des kits de tests rapides profitent à l’ensemble du marché.
En 2022, INEX Innovate, fabricant de produits de diagnostic basé à Singapour, pionnier du secteur de la santé féminine et fœtale en Asie, a reçu le marquage CE pour OvaCis Rapid Test, sa solution phare pour le cancer de l\'ovaire. D\'ici fin 2022, OvaCis, le premier test en son genre au point d\'intervention (POCT) qui distingue les kystes ovariens bénins des malins dans une salle d\'opération, devrait faire ses débuts dans l\'UE et en Asie du Sud-Est. marchés.
En janvier 2022, OraSure Technologies, Inc., un leader mondial des tests de diagnostic au point d\'intervention et à domicile ainsi que des technologies de prélèvement d\'échantillons, a lancé l\'autotest du VIH OraQuick, un écouvillon oral basé sur -test à domicile pour le VIH-1 et le VIH-2, pour le marché européen. Le test est accessible dans six pays européens : le Royaume-Uni, la France, l\'Allemagne, l\'Italie, l\'Espagne et le Portugal.
En 2021, suite à la délivrance du certificat CE, FUJIFILM Europe GmbH a été autorisée à appliquer le marquage CE et à introduire un kit de test d\'antigène pour le diagnostic de l\'infection par le SRAS-CoV-2. La technique utilisée par Fujifilm est appelée immunochromatographie exclusive à amplification argentique et elle est basée sur la même technologie que celle utilisée pour amplifier les photos à développer.
En décembre 2020, la Food and Drug Administration (FDA) des États-Unis a délivré une autorisation d\'utilisation d\'urgence (EUA) pour un test rapide BinaxNOW COVID-19 Ag Card (par Abbott) guidé virtuellement, indiqué pour le test à domicile. utilisation pour la détection du COVID-19. BinaxNOW est un test rapide largement distribué et l\'un des plus abordables, qui fournit des résultats en quelques minutes.
En juillet 2020, la FDA a accordé une autorisation d\'utilisation d\'urgence (EUA) pour un test de diagnostic rapide du SRAS-CoV-2 au point d\'intervention, à utiliser avec son système BD Veritor Plus largement disponible. Le nouveau test génère des résultats en 15 minutes sur un instrument facile à utiliser et hautement portable. Le test visait à améliorer l’accès aux diagnostics du COVID-19 en fournissant des résultats en temps réel et en facilitant une prise de décision rapide pendant que le patient est encore dans le centre de test.
Aperçu du marché européen des kits de test rapide
La prévalence du diabète en Allemagne a augmenté de manière significative. Selon la Fédération internationale du diabète, en 2021, environ 62 millions de personnes souffraient de diabète. De plus, selon le rapport du Centre européen de prévention et de contrôle des maladies, 8 641 cas de paludisme ont été enregistrés dans l’Union européenne (UE) en 2019, dont 8 638 (>99 %) étaient des diagnostics confirmés. En septembre 2022, l\'Allemagne a signé un accord d\'une valeur de 1,34 milliard de dollars avec le Programme commun des Nations Unies sur le VIH/SIDA (ONUSIDA) visant à lutter contre le sida, la tuberculose et le paludisme ; grâce à cela, le pays a augmenté sa contribution de 30 % par rapport à 2019. De plus, selon le rapport endmalaria.org 2020, les sources internationales ont fourni 69 % du financement total visant au contrôle et à l\'élimination du paludisme. Le financement total de la lutte contre le paludisme et de son élimination s\'élève à 3,3 milliards de dollars, dont 0,2 milliard de dollars apportés par l\'Allemagne. Ainsi, le marché des kits de tests rapides devrait croître en Allemagne dans les années à venir avec la prévalence croissante de maladies infectieuses telles que le diabète, le sida, la tuberculose et le paludisme.
Revenus et prévisions du marché des kits de test rapide en Europe jusqu\'en 2030 (millions de dollars américains)
Segmentation du marché des kits de test rapide en Europe
Le marché des kits de test rapide en Europe est segmenté en fonction du type , produit, technologie, application, utilisateur final et pays. En fonction du type, le marché européen des kits de test rapide est segmenté en tests rapides d’antigènes, tests rapides d’anticorps et autres. Le segment des tests rapides d\'antigène détenait la plus grande part de marché en 2022.
En termes de produits, le marché européen des kits de test rapide est divisé en kits de tests rapides en vente libre et en kits de tests rapides professionnels. Le segment des kits de test rapide en vente libre détenait une part de marché plus importante en 2022.
Par technologie, le marché européen des kits de test rapide est segmenté en test à flux latéral, phase solide, agglutination, test immunospot et test cellulaire. basé sur les composants. Le segment des tests à flux latéral détenait la plus grande part de marché en 2022.
Sur la base des applications, le marché européen des kits de test rapide est classé en tests de glycémie, tests de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques et autres. Le segment des tests de glycémie détenait la plus grande part de marché en 2022.
En termes d\'utilisateur final, le marché européen des kits de test rapide est segmenté en hôpitaux et cliniques, soins à domicile, centres de diagnostic et autres. Le segment des hôpitaux et des cliniques détenait la plus grande part de marché en 2022.
En fonction des pays, le marché européen des kits de test rapide est segmenté entre le Royaume-Uni, l\'Allemagne, la France, l\'Italie, l\'Espagne et le reste de l\'Europe. L\'Allemagne a dominé la part de marché des kits de test rapide en Europe en 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA et Beckman Coulter Inc font partie des principaux acteurs opérant sur le marché européen des kits de tests rapides.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - Europe Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. Europe Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Rapid Test Kits Market - Country Analysis
11.1 Europe
11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 United Kingdom
11.1.1.3.1 Overview
11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 France
11.1.1.5.1 Overview
11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
11.1.1.7 Italy
11.1.1.7.1 Overview
11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
11.1.1.9 Spain
11.1.1.9.1 Overview
11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
11.1.1.11 Rest of Europe
11.1.1.11.1 Overview
11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Partec GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Fujirebio Europe NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cepheid
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Meril Life Sciences Pvt Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN NV
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OraSure Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Guangzhou Wondfo Biotech Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Denka Co Ltd
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Abbott Laboratories
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Trinity Biotech Plc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Premier Medical Corp Pvt Ltd
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Beckman Coulter Inc
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. Sysmex Partec GmbH
4. ARKRAY Inc
5. Fujirebio Europe NV
6. bioMerieux SA
7. Cepheid
8. Meril Life Sciences Pvt Ltd
9. QIAGEN NV
10. OraSure Technologies Inc
11. Guangzhou Wondfo Biotech Co Ltd
12. Denka Co Ltd
13. Abbott Laboratories
14. Trinity Biotech Plc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. Premier Medical Corp Pvt Ltd
18. DiaSorin SpA
19. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.